Cannabis Leaf Extract Showed Anti-Inflammatory and Antidepressant Effects in Mice

What the researchers found

Cannabis leaf extract (30 mg/kg) reduced immobility in the forced swimming test and increased sucrose preference in LPS-challenged mice, suggesting antidepressant effects. It also improved oxygen levels and inhibited mast cell degranulation in deep cervical lymph nodes. In brain microglial cells, the extracts suppressed multiple inflammatory markers including IL-1B, IL-6, TNF-A, iNOS, and COX-2.

Why it matters

Neuroinflammation is increasingly recognized as a driver of depression. This study suggests cannabis extracts may work through anti-inflammatory mechanisms in the brain, with the combined action of multiple compounds (the "entourage effect") potentially more important than any single cannabinoid.

The numbers in context

Dose: 30 mg/kg cannabis leaf extract. Main compounds: THCA (a cannabinoid) and B-caryophyllene (a terpene). Six inflammatory markers suppressed in microglial cells: IL-1B, IL-6, TNF-A, nitrite, iNOS, COX-2.

How the study worked

Combined in vivo (mouse inflammation model using LPS) and in vitro (BV2 microglial cell culture) experiments. Mice received 30 mg/kg cannabis leaf extract one hour before LPS administration. Behavioral tests and inflammatory markers were assessed. The main bioactive components were THCA and B-caryophyllene.

What this study cannot tell us

Animal study with a single dose tested in vivo. The LPS model of inflammation-induced depression does not fully recapitulate human depression. The relative contributions of individual compounds within the extract cannot be determined from this design.

How to read the evidence

Preclinical study with both in vivo and in vitro components, but animal results require human validation.

When this study was published

2024 study

The bigger picture

Most cannabis research focuses on THC and CBD in isolation. This study used whole-plant extracts and attributed efficacy to the combined action of multiple phytochemicals, adding to the debate about whether whole-plant preparations offer advantages over isolated compounds.

Questions still open

• Would THCA or B-caryophyllene alone produce the same effects, or is the combination essential? Do these anti-inflammatory effects translate to human depression? What dose range would be relevant for clinical application?

Common questions

Read the original research

In Vitro and In Vivo Anti-Inflammatory and Antidepressant-like Effects of Cannabis sativa L. Extracts.

Plants (Basel, Switzerland), 13(12)

Citation

Shin, Joonyoung; Choi, Sangheon; Park, A Yeong; Ju, Suk; Kweon, Bitna; Kim, Dong-Uk; Bae, Gi-Sang; Han, Dongwoon; Kwon, Eunjeong; Hong, Jongki; Kim, Sungchul. (2024). In Vitro and In Vivo Anti-Inflammatory and Antidepressant-like Effects of Cannabis sativa L. Extracts.. Plants (Basel, Switzerland), 13(12). https://doi.org/10.3390/plants13121619

Explore the wider topic

• CBD Oil Quality Guide: How to Avoid Snake Oil
• Anxiety After Quitting Weed: When to Consider Medication
• Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
• Cannabis for Chronic Pain: What the Research Actually Supports
• Cannabis and Epilepsy: The Epidiolex Story and What It Means
• Does CBD Actually Work for Anxiety? What the Evidence Shows
• Does CBD Help with Weed Withdrawal? What Studies Show
• CBD vs THC: The Differences That Actually Matter
• The Proven Medical Benefits of Cannabis: What Research Supports
• Quitting Weed Before Surgery
• Weed and Medications: What Changes When You Quit
• Quitting Weed During Pregnancy: What You Need to Know
• Quitting Weed While Pregnant: What You Need to Know
• Cannabis and Older Adults: Risks Seniors Should Know
• Cannabis and Breastfeeding: THC in Breast Milk